Imunon has confirmed the deprioritization of its COVID-19 vaccine program. With the company’s cash reserves falling below $5 ...

A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with ...

Vaccines help protect students, staff, family and the community from serious vaccine-preventable diseases,” a local public ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen, MVA-based vaccines and solid tumor immunotherapies, today issued a statement in response to the U.S.

Only 49% of poll respondents said they trust the Food and Drug Administration or the CDC to make sure vaccines are safe.

“Midlife women often juggle caregiving, careers, and hormonal shifts that can strain the immune system,” Boden-Albala says.

As students prepare to go back to school across Vermont and Northern New York, health care officials are reminding parents to ...

The summer surge of COVID-19 isn’t letting up; in fact, one of the main tools for tracking the virus is showing a jump, according to the latest update from the Centers for Disease Control and ...

We want to know more about what these products are doing,” said Dr. Vinay Prasad in a recent FDA livestreamed presentation. The statement is made as there has been a significant policy shift in the U.

More than 120 nations have signed the new WHO Pandemic Agreement, and the U.S. is scaling its biodefense footprint through mobile biocontainment units, genomic surveillance, and expanded diagnostics.